Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahaj Rathi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|August 13, 2024
Myokines are associated with progression, course and mortality in alcohol-associated liver diseaseParminder Kaur, Nipun Verma, Pratibha Garg, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Identification of four novel acute-on-chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methodsNipun Verma, Pratibha Garg, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology|March 25, 2025
Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)Satender P Singh, Karan Kumar, Anand Kulkarni, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosisNipun Verma, P Venkata Divakar Reddy, Shashi Vig, et al.
JCO Global Oncology|November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)Anant Ramaswamy, Anand Kulkarni, George John, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2025
Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and SurvivalMadhumita Premkumar, Harish Bhujade, Prerna Sharma, et al.
Gastroenterology|August 24, 2024
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination ProgramMadhumita Premkumar, Radha K Dhiman, Ajay Duseja, et al.
Hepatology (Baltimore, Md.)|November 17, 2023
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiographyMadhumita Premkumar, Kamal Kajal, K Rajender Reddy, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2023
Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsisKamal Kajal, Madhumita Premkumar, Manhal Izzy, et al.
Journal of Clinical and Experimental Hepatology|November 17, 2023
Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical TrialRohit Mehtani, Madhumita Premkumar, Shankey Garg, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|August 13, 2024
Myokines are associated with progression, course and mortality in alcohol-associated liver diseaseParminder Kaur, Nipun Verma, Pratibha Garg, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Identification of four novel acute-on-chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methodsNipun Verma, Pratibha Garg, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology|March 25, 2025
Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)Satender P Singh, Karan Kumar, Anand Kulkarni, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosisNipun Verma, P Venkata Divakar Reddy, Shashi Vig, et al.
JCO Global Oncology|November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)Anant Ramaswamy, Anand Kulkarni, George John, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2025
Experience With Dabigatran on Rate of Portal Vein Thrombosis Recanalization, Disease Progression and SurvivalMadhumita Premkumar, Harish Bhujade, Prerna Sharma, et al.
Gastroenterology|August 24, 2024
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination ProgramMadhumita Premkumar, Radha K Dhiman, Ajay Duseja, et al.
Hepatology (Baltimore, Md.)|November 17, 2023
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiographyMadhumita Premkumar, Kamal Kajal, K Rajender Reddy, et al.
Alimentary Pharmacology & Therapeutics|September 9, 2023
Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsisKamal Kajal, Madhumita Premkumar, Manhal Izzy, et al.
Journal of Clinical and Experimental Hepatology|November 17, 2023
Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical TrialRohit Mehtani, Madhumita Premkumar, Shankey Garg, et al.
Pageof 7